R&D Systems™ Recombinant Human Matriptase/ST14 Catalytic Domain, CF

Product Code.	Quantity	unitSize
18716596	10 μg	10µg

Product Code. 18716596 Supplier R&D Systems™ Supplier No. 3946SEB010

Description

Recombinant Protein

Measured by its ability to cleave the fluorogenic peptide substrate Boc-QAR-AMC (Catalog # ES014 ). The specific activity is >10,000 pmol/min/μg, as measured under the described conditions.

Specifications

• Accession Number: NP_068813
• For Use With (Application): Enzyme Activity
• Formulation: Supplied as a 0.2 μm filtered solution in Tris-HCl and Glycerol.
• Gene ID (Entrez): 6768
• Molecular Weight (g/mol): MolecularWeight-observed: 27 kDa (major) and minor auto-activation fragments, reducing conditions, MolecularWeight-theroretical: 26 kDa
• Quantity: 10 μg
• Source: E. coli-derived human Matriptase/ST14 protein Gly596-Val855, with an N-terminal Met and 6-His tag The protein was purified, auto-activated and further purified.
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70°C as supplied. 3 months, -20 to -70°C under sterile conditions after opening.
• Endotoxin Concentration: <1.0 EU per 1 μg of the protein by the LAL method.
• Gene Alias: EC 3.4.21, Epithin, HAI, Matriptase, Membrane-type serine protease 1, MTSP1, MT-SP1EC 3.4.21.109, prostamin, PRSS14, Serine protease 14, Serine protease TADG-15, SNC19, SNC19MTSP1, ST14, suppression of tumorigenicity 14 (colon carcinoma), suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin), suppressor of tumorigenicity 14 protein, TADG15, TADG-15, TMPRSS14, tumor associated differentially expressed gene 15 protein, Tumor-associated differentially-expressed gene 15 protein
• Conjugate: Unconjugated
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: Matriptase/ST14